https://orcid.org/0000-0003-1845-1224
References
- Bik L, Sangers T, Greveling K, et al. (2020). Efficacy and tolerability of intralesional bleomycin in dermatology: a systematic review. J Am Acad Dermatol 20:30226–7.
- Bik L, van Doorn MBA, Biskup E, et al. (2021). Electronic pneumatic injection-assisted dermal drug delivery visualized by ex vivo confocal microscopy. Lasers Surg Med 53:141–7.
- Campana LG, Marconato R, Valpione S, et al. (2017). Basal cell carcinoma: 10-year experience with electrochemotherapy. J Transl Med 15: 122.
- Cavalié M, Sillard L, Montaudié H, et al. (2015). Treatment of keloids with laser-assisted topical steroid delivery: a retrospective study of 23 cases. Dermatol Ther 28:74–78.
- Clover AJP, Salwa SP, Bourke MG, et al. (2020). Electrochemotherapy for the treatment of primary basal cell carcinoma: a randomised control trial comparing electrochemotherapy and surgery with five year follow up. Eur J Surg Oncol 46:847–54.
- Erlendsson AM, Haedersdal M, Rossi AM. (2020). Needle-free injection assisted drug delivery-histological characterization of cutaneous deposition. Lasers Surg Med 52:33–7.
- Gehl J, Sersa G, Matthiessen LW, et al. (2018). Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol 57:874–82.
- Glass LF, Jaroszeski M, Gilbert R, et al. (1997). Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J Am Acad Dermatol 37:596–9.
- Grégoire S, Luengo GS, Hallegot P, et al. (2020). Imaging and quantifying drug delivery in skin – part 1: autoradiography and mass spectrometry imaging. Adv Drug Deliv Rev 153:137–46.
- Groselj A, Krzan M, Kosjek T, et al. (2016). Bleomycin pharmacokinetics of bolus bleomycin dose in elderly cancer patients treated with electrochemotherapy. Cancer Chemother Pharmacol 77:939–47.
- Hendel K, Bagger C, Olesen UH, et al. (2019). Fractional laser-assisted topical delivery of bleomycin quantified by LC-MS and visualized by MALDI mass spectrometry imaging. Drug Deliv 26:244–51.
- Kosjek T, Krajnc A, Gornik T, et al. (2016). Identification and quantification of bleomycin in serum and tumor tissue by liquid chromatography coupled to high resolution mass spectrometry. Talanta 160:164–171.
- Mir LM, Gehl J, Sersa G, et al. (2006). Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes. Eur J Cancer Suppl 4:14–25.
- Mir LM, Glass LF, Sersa G, et al. (1998). Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 77:2336–42.
- Mirza FN, Khatri KA. (2017). The use of lasers in the treatment of skin cancer: A review. J Cosmet Laser Ther 19:451–8.
- Morrow DIJ, Garland MJ, McCarron PA, et al. (2007). Innovative drug delivery strategies for topical photodynamic therapy using porphyrin precursors. J Environ Pathol Toxicol Oncol 26:105–116.
- Navarrete-Dechent C. (2019). Reflectance confocal microscopy-guided carbon dioxide laser ablation of low-risk basal cell carcinomas: a prospective study. J Am Acad Dermatol 81:5.
- Olesen UH, Clergeaud G, Hendel KK, et al. (2020). Enhanced and sustained cutaneous delivery of vismodegib by ablative fractional laser and microemulsion formulation. J Invest Dermatol 140:2051–9.
- Orlowski S, Belehradek J, Paoletti C, Mir LM. (1988). Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 37:4727–33.
- Povirk LF, Hogan M, Dattagupta N. (1979). Binding of bleomycin to DNA: intercalation of the bithiazole rings. Biochemistry 18:96–101.
- Rosenberg LK, Bagger C, Janfelt C, et al. (2021). A comparison of human and porcine skin in laser-assisted drug delivery of chemotherapeutics. Lasers Surg Med 53:162–70.
- Rotunno R, Campana LG, Quaglino P, et al. (2018). Electrochemotherapy of unresectable cutaneous tumours with reduced dosages of intravenous bleomycin: analysis of 57 patients from the International Network for Sharing Practices of Electrochemotherapy registry. J Eur Acad Dermatol Venereol 32:1147–1154.
- Sabri A, Ogilvie J, McKenna J, et al. (2020). Intradermal delivery of an immunomodulator for basal cell carcinoma; expanding the mechanistic insight into solid microneedle-enhanced delivery of hydrophobic molecules. Mol Pharmaceutics 17:2925–37.
- Saitta P, Krishnamurthy K, Brown LH. (2008). Bleomycin in dermatology: a review of intralesional applications: bleomycin in dermatology. Dermatol Surg 34:1299–313.
- Tan J, Zhou J, Huang L, et al. (2021). Hypertrophic scar improvement by early intervention with ablative fractional carbon dioxide laser treatment. Lasers Surg Med 53:450–457.
- Wenande E, Anderson RR, Haedersdal M. (2019). Fundamentals of fractional laser-assisted drug delivery: an in-depth guide to experimental methodology and data interpretation. Adv Drug Deliv Rev 153:169–84.
- Wenande E, Hendel K, Mogensen M, et al. (2021). Efficacy and safety of laser-assisted combination chemotherapy: an explorative imaging-guided treatment with 5-fluorouracil and cisplatin for basal cell carcinoma. Lasers Surg Med 53:119–28.
- Wenande E, Tam J, Bhayana B, et al. (2018). Laser-assisted delivery of synergistic combination chemotherapy in in vivo skin. J Control Release 275:242–53.
- White DR, Griffith RV, Wilson IJ. (1992). Report 46. J Int Commission Radiation Units Measurements os24:NP.